SRPT Annual D&A
$44.40 M
+$2.53 M+6.05%
31 December 2023
Summary:
As of January 22, 2025, SRPT annual depreciation & amortization is $44.40 million, with the most recent change of +$2.53 million (+6.05%) on December 31, 2023. During the last 3 years, it has risen by +$17.49 million (+64.98%). SRPT annual D&A is now at all-time high.SRPT Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT Quarterly D&A
$9.81 M
+$1.09 M+12.47%
30 September 2024
Summary:
As of January 22, 2025, SRPT quarterly depreciation & amortization is $9.81 million, with the most recent change of +$1.09 million (+12.47%) on September 30, 2024. Over the past year, it has dropped by -$1.57 million (-13.77%). SRPT quarterly D&A is now -13.77% below its all-time high of $11.37 million, reached on December 31, 2023.SRPT Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT TTM D&A
$38.64 M
-$1.12 M-2.82%
30 September 2024
Summary:
As of January 22, 2025, SRPT TTM depreciation & amortization is $38.64 million, with the most recent change of -$1.12 million (-2.82%) on September 30, 2024. Over the past year, it has dropped by -$5.76 million (-12.96%). SRPT TTM D&A is now -12.96% below its all-time high of $44.40 million, reached on December 31, 2023.SRPT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.0% | -13.8% | -13.0% |
| 3 y3 years | +65.0% | -8.4% | -6.8% |
| 5 y5 years | +262.6% | -8.4% | -6.8% |
SRPT Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +16.8% | -13.8% | +12.5% | -13.0% | +1.6% |
| 5 y | 5-year | at high | +81.2% | -13.8% | +51.4% | -13.0% | +57.7% |
| alltime | all time | at high | >+9999.0% | -13.8% | +2389.5% | -13.0% | >+9999.0% |
Sarepta Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $9.81 M(+12.5%) | $38.64 M(-2.8%) |
| June 2024 | - | $8.72 M(-0.3%) | $39.76 M(-5.0%) |
| Mar 2024 | - | $8.74 M(-23.1%) | $41.84 M(-5.8%) |
| Dec 2023 | $44.40 M(+6.1%) | $11.37 M(+4.1%) | $44.40 M(+1.9%) |
| Sept 2023 | - | $10.93 M(+1.3%) | $43.58 M(+0.5%) |
| June 2023 | - | $10.79 M(-4.5%) | $43.35 M(+2.1%) |
| Mar 2023 | - | $11.30 M(+7.1%) | $42.45 M(+1.4%) |
| Dec 2022 | $41.86 M(+10.1%) | $10.55 M(-1.4%) | $41.86 M(+1.0%) |
| Sept 2022 | - | $10.70 M(+8.2%) | $41.46 M(+0.5%) |
| June 2022 | - | $9.89 M(-7.7%) | $41.25 M(+3.6%) |
| Mar 2022 | - | $10.72 M(+5.7%) | $39.81 M(+4.7%) |
| Dec 2021 | $38.02 M(+41.3%) | $10.14 M(-3.3%) | $38.02 M(+8.1%) |
| Sept 2021 | - | $10.49 M(+24.2%) | $35.16 M(+12.4%) |
| June 2021 | - | $8.45 M(-5.4%) | $31.28 M(+6.7%) |
| Mar 2021 | - | $8.93 M(+22.5%) | $29.31 M(+8.9%) |
| Dec 2020 | $26.91 M(+9.8%) | $7.29 M(+10.1%) | $26.91 M(+2.4%) |
| Sept 2020 | - | $6.62 M(+2.2%) | $26.27 M(-0.5%) |
| June 2020 | - | $6.47 M(-0.8%) | $26.39 M(+0.9%) |
| Mar 2020 | - | $6.53 M(-1.8%) | $26.15 M(+6.7%) |
| Dec 2019 | $24.50 M(+100.1%) | $6.65 M(-1.4%) | $24.50 M(+14.6%) |
| Sept 2019 | - | $6.74 M(+8.1%) | $21.38 M(+17.3%) |
| June 2019 | - | $6.23 M(+27.8%) | $18.23 M(+22.6%) |
| Mar 2019 | - | $4.88 M(+38.3%) | $14.87 M(+21.5%) |
| Dec 2018 | $12.24 M(+51.3%) | $3.53 M(-1.8%) | $12.24 M(+12.9%) |
| Sept 2018 | - | $3.59 M(+25.1%) | $10.84 M(+10.5%) |
| June 2018 | - | $2.87 M(+27.6%) | $9.81 M(+12.6%) |
| Mar 2018 | - | $2.25 M(+6.0%) | $8.71 M(+7.6%) |
| Dec 2017 | $8.09 M(+44.2%) | $2.12 M(-17.0%) | $8.09 M(+6.0%) |
| Sept 2017 | - | $2.56 M(+44.4%) | $7.63 M(+24.2%) |
| June 2017 | - | $1.77 M(+8.2%) | $6.15 M(+5.1%) |
| Mar 2017 | - | $1.64 M(-1.6%) | $5.85 M(+4.3%) |
| Dec 2016 | $5.61 M(+6.9%) | $1.66 M(+54.9%) | $5.61 M(+5.6%) |
| Sept 2016 | - | $1.07 M(-27.2%) | $5.31 M(-4.3%) |
| June 2016 | - | $1.48 M(+5.7%) | $5.55 M(+3.4%) |
| Mar 2016 | - | $1.40 M(+2.4%) | $5.36 M(+2.2%) |
| Dec 2015 | $5.25 M(+42.2%) | $1.36 M(+4.0%) | $5.25 M(+4.1%) |
| Sept 2015 | - | $1.31 M(+1.6%) | $5.04 M(+5.5%) |
| June 2015 | - | $1.29 M(+0.9%) | $4.78 M(+7.4%) |
| Mar 2015 | - | $1.28 M(+10.5%) | $4.45 M(+20.5%) |
| Dec 2014 | $3.69 M(+189.0%) | $1.16 M(+10.4%) | $3.69 M(+31.3%) |
| Sept 2014 | - | $1.05 M(+9.3%) | $2.81 M(+37.2%) |
| June 2014 | - | $960.00 K(+83.6%) | $2.05 M(+51.9%) |
| Mar 2014 | - | $523.00 K(+87.5%) | $1.35 M(+5.6%) |
| Dec 2013 | $1.28 M(-16.3%) | $279.00 K(-2.8%) | $1.28 M(-10.9%) |
| Sept 2013 | - | $287.00 K(+10.4%) | $1.43 M(-5.8%) |
| June 2013 | - | $260.00 K(-42.4%) | $1.52 M(-6.3%) |
| Mar 2013 | - | $451.00 K(+3.7%) | $1.62 M(+6.4%) |
| Dec 2012 | $1.52 M(+17.3%) | $435.00 K(+16.0%) | $1.52 M(-6.3%) |
| Sept 2012 | - | $375.00 K(+3.6%) | $1.63 M(+6.7%) |
| June 2012 | - | $362.00 K(+2.5%) | $1.52 M(+7.9%) |
| Mar 2012 | - | $353.00 K(-34.3%) | $1.41 M(+8.8%) |
| Dec 2011 | $1.30 M(-11.1%) | $537.00 K(+96.7%) | $1.30 M(+10.8%) |
| Sept 2011 | - | $273.00 K(+8.8%) | $1.17 M(-6.5%) |
| June 2011 | - | $251.00 K(+5.0%) | $1.25 M(-7.4%) |
| Mar 2011 | - | $239.00 K(-41.7%) | $1.35 M(-7.4%) |
| Dec 2010 | $1.46 M | $410.00 K(+15.5%) | $1.46 M(+8.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2010 | - | $355.00 K(+1.1%) | $1.35 M(-0.1%) |
| June 2010 | - | $351.00 K(+1.2%) | $1.35 M(-0.4%) |
| Mar 2010 | - | $347.00 K(+16.1%) | $1.36 M(-1.5%) |
| Dec 2009 | $1.38 M(-6.1%) | $299.00 K(-16.2%) | $1.38 M(-8.4%) |
| Sept 2009 | - | $357.00 K(+0.3%) | $1.51 M(+0.7%) |
| June 2009 | - | $356.00 K(-3.0%) | $1.50 M(+0.5%) |
| Mar 2009 | - | $367.00 K(-13.8%) | $1.49 M(+1.2%) |
| Dec 2008 | $1.47 M(-27.1%) | $425.60 K(+22.9%) | $1.47 M(-5.3%) |
| Sept 2008 | - | $346.40 K(-0.5%) | $1.55 M(-11.0%) |
| June 2008 | - | $348.00 K(-0.3%) | $1.74 M(-7.5%) |
| Mar 2008 | - | $349.00 K(-31.2%) | $1.88 M(-6.5%) |
| Dec 2007 | $2.01 M(-3.7%) | $507.10 K(-5.9%) | $2.01 M(-1.1%) |
| Sept 2007 | - | $538.70 K(+10.3%) | $2.04 M(+0.8%) |
| June 2007 | - | $488.50 K(+1.9%) | $2.02 M(-1.2%) |
| Mar 2007 | - | $479.60 K(-9.5%) | $2.04 M(-2.2%) |
| Dec 2006 | $2.09 M(+4.6%) | $529.70 K(+1.3%) | $2.09 M(-0.0%) |
| Sept 2006 | - | $522.70 K(+1.9%) | $2.09 M(+1.5%) |
| June 2006 | - | $512.80 K(-2.3%) | $2.06 M(+1.0%) |
| Mar 2006 | - | $525.10 K(-0.9%) | $2.04 M(+2.1%) |
| Dec 2005 | $2.00 M(+5.8%) | $530.10 K(+7.8%) | $2.00 M(+0.6%) |
| Sept 2005 | - | $491.90 K(+0.1%) | $1.99 M(-30.6%) |
| June 2005 | - | $491.60 K(+1.6%) | $2.86 M(+47.3%) |
| Mar 2005 | - | $484.00 K(-6.7%) | $1.94 M(+3.0%) |
| Dec 2004 | $1.89 M(+27.2%) | $518.60 K(-62.1%) | $1.89 M(+3.4%) |
| Sept 2004 | - | $1.37 M(-419.7%) | $1.83 M(+126.5%) |
| June 2004 | - | -$428.30 K(-200.0%) | $805.90 K(-49.0%) |
| Mar 2004 | - | $428.30 K(-6.1%) | $1.58 M(+6.4%) |
| Dec 2003 | $1.48 M(+11.3%) | $456.20 K(+30.5%) | $1.48 M(+5.5%) |
| Sept 2003 | - | $349.70 K(+1.3%) | $1.41 M(+0.1%) |
| June 2003 | - | $345.30 K(+3.6%) | $1.41 M(+0.3%) |
| Mar 2003 | - | $333.20 K(-12.1%) | $1.40 M(+5.0%) |
| Dec 2002 | $1.33 M(+139.6%) | $379.00 K(+8.9%) | $1.33 M(+12.0%) |
| Sept 2002 | - | $347.90 K(+2.2%) | $1.19 M(+24.1%) |
| June 2002 | - | $340.40 K(+28.0%) | $959.90 K(+31.6%) |
| Mar 2002 | - | $266.00 K(+12.5%) | $729.40 K(+31.1%) |
| Dec 2001 | $556.50 K(+33.6%) | $236.50 K(+102.1%) | $556.50 K(+11.0%) |
| Sept 2001 | - | $117.00 K(+6.5%) | $501.30 K(+6.5%) |
| June 2001 | - | $109.90 K(+18.0%) | $470.80 K(+7.8%) |
| Mar 2001 | - | $93.10 K(-48.6%) | $436.90 K(+4.9%) |
| Dec 2000 | $416.50 K(+38.8%) | $181.30 K(+109.6%) | $416.50 K(+24.3%) |
| Sept 2000 | - | $86.50 K(+13.8%) | $335.20 K(-3.9%) |
| June 2000 | - | $76.00 K(+4.5%) | $348.70 K(+27.9%) |
| Mar 2000 | - | $72.70 K(-27.3%) | $272.70 K(-9.1%) |
| Dec 1999 | $300.00 K(+50.0%) | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| Sept 1999 | - | $100.00 K(>+9900.0%) | $200.00 K(0.0%) |
| June 1999 | - | $0.00(-100.0%) | $200.00 K(0.0%) |
| Mar 1999 | - | $100.00 K(>+9900.0%) | $200.00 K(0.0%) |
| Dec 1998 | $200.00 K(-60.0%) | $0.00(-100.0%) | $200.00 K(-50.0%) |
| Sept 1998 | - | $100.00 K(>+9900.0%) | $400.00 K(+33.3%) |
| June 1998 | - | $0.00(-100.0%) | $300.00 K(-40.0%) |
| Mar 1998 | - | $100.00 K(-50.0%) | $500.00 K(0.0%) |
| Dec 1997 | $500.00 K(0.0%) | $200.00 K(>+9900.0%) | $500.00 K(+66.7%) |
| Sept 1997 | - | $0.00(-100.0%) | $300.00 K(0.0%) |
| June 1997 | - | $200.00 K(+100.0%) | $300.00 K(+200.0%) |
| Mar 1997 | - | $100.00 K | $100.00 K |
| Dec 1996 | $500.00 K | - | - |
FAQ
- What is Sarepta Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual D&A year-on-year change?
- What is Sarepta Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly D&A year-on-year change?
- What is Sarepta Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Sarepta Therapeutics?
- What is Sarepta Therapeutics TTM D&A year-on-year change?
What is Sarepta Therapeutics annual depreciation & amortization?
The current annual D&A of SRPT is $44.40 M
What is the all time high annual D&A for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual depreciation & amortization is $44.40 M
What is Sarepta Therapeutics annual D&A year-on-year change?
Over the past year, SRPT annual depreciation & amortization has changed by +$2.53 M (+6.05%)
What is Sarepta Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of SRPT is $9.81 M
What is the all time high quarterly D&A for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly depreciation & amortization is $11.37 M
What is Sarepta Therapeutics quarterly D&A year-on-year change?
Over the past year, SRPT quarterly depreciation & amortization has changed by -$1.57 M (-13.77%)
What is Sarepta Therapeutics TTM depreciation & amortization?
The current TTM D&A of SRPT is $38.64 M
What is the all time high TTM D&A for Sarepta Therapeutics?
Sarepta Therapeutics all-time high TTM depreciation & amortization is $44.40 M
What is Sarepta Therapeutics TTM D&A year-on-year change?
Over the past year, SRPT TTM depreciation & amortization has changed by -$5.76 M (-12.96%)